Evaluating 5 Alpha Reductase Inhibitors for the Treatment of Male Androgenic Alopecia

    November 2023 in “ Expert Opinion on Pharmacotherapy
    Ashling Courtney, Daranporn Triwongwarant, Ivana Chim, Samantha Eisman, Rodney Sinclair
    Image of study
    TLDR Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.
    The document evaluates the effectiveness of 5 alpha reductase inhibitors (5ARIs), specifically finasteride and dutasteride, in treating male androgenic alopecia (AGA), a hair-loss disorder. Finasteride, approved by the FDA in 1997, reduces scalp and serum dihydrotestosterone (DHT) by 64% and 68% respectively, halting AGA in at least 90% of men and promoting hair regrowth in 48% at 12 months and 66% at 48 months. However, it can cause reduced libido and erectile dysfunction. Dutasteride, more potent than finasteride, decreases DHT more significantly but has a higher risk of sexual side effects. Both drugs can cause birth defects and are not recommended during pregnancy. The authors suggest 5ARIs for early and long-term use to prevent baldness, but discontinuation leads to loss of effect and return to baseline hair density at 6 months.
    Discuss this study in the Community →

    Cited in this study

    9 / 9 results

    Related

    5 / 5 results